Extracellular Tropomyosin: A Novel Common Pathway Target for Anti- Angiogenic Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|7|543-553

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.7, 2004-01, pp. : 543-553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Target-based Anti-angiogenic Therapy in Breast Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4244-4257

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy

By  

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 1000-1017

Bentham Science Publishers

Access to resources Recommend Favorite

Implication of Heat Shock Protein 90 (HSP90) in Tumor Angiogenesis: A Molecular Target for Anti-Angiogenic Therapy?

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 890-897

Bentham Science Publishers

Access to resources Recommend Favorite

MK2: a novel molecular target for anti-inflammatory therapy

By Duraisamy Senthil   Bajpai Malini   Bughani Usha   Dastidar Sunanda G   Ray Abhijit   Chopra Puneet  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 921-936

Informa Healthcare

Access to resources Recommend Favorite

Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Antiatherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1147-1151

Bentham Science Publishers

Access to resources Recommend Favorite